{"id":"https://openalex.org/W2608559677","doi":"https://doi.org/10.3233/jad-160965","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 ( scyllo -Inositol) in Young Adults with Down Syndrome without Dementia","display_name":"A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 ( scyllo -Inositol) in Young Adults with Down Syndrome without Dementia","publication_year":2017,"publication_date":"2017-04-25","ids":{"openalex":"https://openalex.org/W2608559677","doi":"https://doi.org/10.3233/jad-160965","mag":"2608559677","pmid":"https://pubmed.ncbi.nlm.nih.gov/28453471","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5777855"},"language":"en","primary_location":{"id":"doi:10.3233/jad-160965","doi":"https://doi.org/10.3233/jad-160965","is_oa":false,"landing_page_url":"https://doi.org/10.3233/jad-160965","pdf_url":null,"source":{"id":"https://openalex.org/S25155249","display_name":"Journal of Alzheimer s Disease","issn_l":"1387-2877","issn":["1387-2877","1875-8908"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Alzheimer\u2019s Disease","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5777855","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026799001","display_name":"Michael S. Rafii","orcid":"https://orcid.org/0000-0003-2640-2094","observed_orcids":["https://orcid.org/0000-0003-2640-2094"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael S. Rafii","raw_affiliation_strings":["Alzheimer\u2019s Therapeutic Research Institute (ATRI) at University of Southern California, San Diego, CA, USA","Department of Neurosciences, University of California, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimer\u2019s Therapeutic Research Institute (ATRI) at University of Southern California, San Diego, CA, USA","institution_ids":["https://openalex.org/I1174212"]},{"raw_affiliation_string":"Department of Neurosciences, University of California, San Diego, CA, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087067193","display_name":"Brian G. Skotko","orcid":"https://orcid.org/0000-0002-5232-9882","observed_orcids":["https://orcid.org/0000-0002-5232-9882"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian G. Skotko","raw_affiliation_strings":["Department of Pediatrics, Down Syndrome Program, Division of Medical Genetics, Massachusetts General Hospital, Boston, MA, USA","Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Down Syndrome Program, Division of Medical Genetics, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067674891","display_name":"Mary Ellen McDonough","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Ellen McDonough","raw_affiliation_strings":["Department of Pediatrics, Down Syndrome Program, Division of Medical Genetics, Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Down Syndrome Program, Division of Medical Genetics, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001736395","display_name":"Margaret B. Pulsifer","orcid":"https://orcid.org/0000-0003-3160-4846","observed_orcids":["https://orcid.org/0000-0003-3160-4846"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret Pulsifer","raw_affiliation_strings":["Department of Psychiatry, Psychology Assessment Center, Massachusetts General Hospital, Boston, MA, USA","Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Psychology Assessment Center, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013611409","display_name":"Casey L. Evans","orcid":"https://orcid.org/0000-0003-1723-2636","observed_orcids":["https://orcid.org/0000-0003-1723-2636"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Casey Evans","raw_affiliation_strings":["Department of Psychiatry, Psychology Assessment Center, Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Psychology Assessment Center, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111192593","display_name":"Eric W. Doran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Doran","raw_affiliation_strings":["Department of Pediatrics, University of California, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, University of California, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055093575","display_name":"Gabriela Muranevici","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriela Muranevici","raw_affiliation_strings":["Department of Neurosciences, University of California, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosciences, University of California, San Diego, CA, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109311169","display_name":"Patrick J. Kesslak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Kesslak","raw_affiliation_strings":["ACADIA Pharmaceuticals, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals, San Diego, CA, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113687686","display_name":"Susan R. Abushakra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan Abushakra","raw_affiliation_strings":["Alzheon, Inc., Framingham, MA, USA","E-mail:"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon, Inc., Framingham, MA, USA","institution_ids":[]},{"raw_affiliation_string":"E-mail:","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090002053","display_name":"Ira T. Lott","orcid":"https://orcid.org/0000-0002-3107-0752","observed_orcids":["https://orcid.org/0000-0002-3107-0752"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ira T. Lott","raw_affiliation_strings":["Department of Pediatrics, University of California, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, University of California, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"last","author":{"id":null,"display_name":"for the ELND005-DS Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"for the ELND005-DS Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5026799001"],"corresponding_institution_ids":["https://openalex.org/I1174212","https://openalex.org/I36258959"],"apc_list":null,"apc_paid":null,"fwci":3.2341,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.91411063,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"58","issue":"2","first_page":"401","last_page":"411"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5938000082969666,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5938000082969666,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11015","display_name":"Down syndrome and intellectual disability research","score":0.3822999894618988,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/scyllo-inositol","display_name":"scyllo-inositol","score":0.9620000123977661}],"concepts":[{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.7649841904640198},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.7266378402709961},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6552847623825073},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.509725034236908},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4632517099380493},{"id":"https://openalex.org/C2777427919","wikidata":"https://www.wikidata.org/wiki/Q407997","display_name":"Inositol","level":3,"score":0.46231114864349365},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3750153183937073},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09977152943611145},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.07046973705291748},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06863945722579956},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.06819590926170349}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004314","descriptor_name":"Down Syndrome","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D004314","descriptor_name":"Down Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D004314","descriptor_name":"Down Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007294","descriptor_name":"Inositol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007294","descriptor_name":"Inositol","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.3233/jad-160965","doi":"https://doi.org/10.3233/jad-160965","is_oa":false,"landing_page_url":"https://doi.org/10.3233/jad-160965","pdf_url":null,"source":{"id":"https://openalex.org/S25155249","display_name":"Journal of Alzheimer s Disease","issn_l":"1387-2877","issn":["1387-2877","1875-8908"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Alzheimer\u2019s Disease","raw_type":"journal-article"},{"id":"pmid:28453471","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28453471","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Alzheimer's disease : JAD","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:europepmc.org:4685851","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5777855","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5777855","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5777855","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Alzheimers Dis","raw_type":"Text"},{"id":"pmh:oai:escholarship.org/ark:/13030/qt1299n2kb","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/1299n2kb","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Alzheimer's disease : JAD, vol 58, iss 2","raw_type":"article"},{"id":"pmh:qt1299n2kb","doi":null,"is_oa":true,"landing_page_url":"http://www.escholarship.org/uc/item/1299n2kb","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Rafii, Michael S; Skotko, Brian G; McDonough, Mary Ellen; Pulsifer, Margaret; Evans, Casey; Doran, Eric; \u00c2\u00a0et al.(2017). A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.. Journal of Alzheimer's disease : JAD, 58(2), 401 - 411. UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/1299n2kb","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:4685851","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5777855","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8299999833106995,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G3804978007","display_name":"Institute for Clinical and Translational Science","funder_award_id":"UL1TR001414","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G4358608740","display_name":"The Alzheimer's Disease Research Center at the University of California, Irvine","funder_award_id":"P50AG016573","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G8634814249","display_name":"Institute for Clinical and Translational Science","funder_award_id":"UL1TR000153","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332688","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W38490725","https://openalex.org/W1583192908","https://openalex.org/W1714940191","https://openalex.org/W1935009340","https://openalex.org/W1975081381","https://openalex.org/W1981458288","https://openalex.org/W1992093172","https://openalex.org/W1996997118","https://openalex.org/W2033178632","https://openalex.org/W2041789591","https://openalex.org/W2049717740","https://openalex.org/W2050529442","https://openalex.org/W2057109662","https://openalex.org/W2074666700","https://openalex.org/W2085560767","https://openalex.org/W2108216694","https://openalex.org/W2111963393","https://openalex.org/W2114682707","https://openalex.org/W2117313690","https://openalex.org/W2119197968","https://openalex.org/W2134774579","https://openalex.org/W2147257653","https://openalex.org/W2148080316","https://openalex.org/W2154485072","https://openalex.org/W2158672664","https://openalex.org/W2162971233","https://openalex.org/W2169934464","https://openalex.org/W2337428295","https://openalex.org/W2340651303","https://openalex.org/W2347148793","https://openalex.org/W3197970345","https://openalex.org/W4246550352","https://openalex.org/W4299711264"],"related_works":["https://openalex.org/W2110987017","https://openalex.org/W2108851969","https://openalex.org/W2119197968","https://openalex.org/W2005390553","https://openalex.org/W2057992381","https://openalex.org/W2016573373","https://openalex.org/W4242800633","https://openalex.org/W1979100063","https://openalex.org/W2127642100","https://openalex.org/W2001454508"],"abstract_inverted_index":{"BACKGROUND:":[0],"ELND005":[1,37,84,109,173,196],"(scyllo-Inositol;":[2],"cyclohexane-1,2,3,4,5,6-hexol)":[3],"has":[4],"been":[5],"evaluated":[6],"as":[7],"a":[8,67,102],"potential":[9],"disease-modifying":[10],"treatment":[11,134,190],"for":[12,25,87,126],"Alzheimer's":[13],"disease":[14],"(AD).":[15],"Individuals":[16],"with":[17,60,178,185,193,195],"Down":[18],"syndrome":[19],"(DS)":[20],"have":[21],"an":[22],"increased":[23],"risk":[24],"developing":[26],"AD":[27],"dementia.":[28,63],"OBJECTIVE:":[29],"To":[30],"evaluate":[31],"the":[32,79,151],"safety":[33,49,80,210],"and":[34,38,44,52,81,142,147,167,181,207],"tolerability":[35],"of":[36,78,83,191],"to":[39,107,183,217],"determine":[40],"its":[41],"pharmacokinetics":[42,82],"(PK)":[43],"relationship":[45],"between":[46],"PK":[47],"parameters,":[48,161],"outcome":[50,55],"measures,":[51],"exploratory":[53],"efficacy":[54],"measures":[56,141],"in":[57,101,150,158],"young":[58],"adults":[59,192],"DS":[61,194],"without":[62],"METHODS:":[64],"This":[65],"was":[66,200],"prospective,":[68],"randomized,":[69],"double-blind,":[70],"placebo-controlled,":[71],"parallel-group,":[72],"three-arm,":[73],"multicenter":[74],"Phase":[75],"II":[76],"study":[77,95],"administered":[85],"orally":[86],"4":[88,127],"weeks":[89],"(ClinicalTrials.gov":[90],"NCT01791725).":[91],"Participants":[92],"who":[93],"met":[94],"eligibility":[96],"criteria":[97],"were":[98,131,144,171],"randomly":[99],"assigned":[100],"2":[103],":":[104],"1:1":[105],"ratio":[106],"receive":[108],"at":[110,197],"either":[111],"250":[112,118],"mg":[113,119],"twice":[114],"daily":[115,121],"(BID)":[116],"or":[117,123,139],"once":[120],"(QD)":[122],"matching":[124],"placebo":[125],"weeks.":[128],"RESULTS:":[129],"There":[130],"no":[132,145,148,209],"apparent":[133],"group-related":[135],"trends":[136],"on":[137],"cognitive":[138],"behavioral":[140],"there":[143],"SAEs":[146],"deaths":[149],"study.":[152],"Overall,":[153,189],"mean":[154],"changes":[155],"from":[156],"baseline":[157],"clinical":[159],"laboratory":[160],"vital":[162],"sign":[163],"measurements,":[164],"electrocardiogram":[165],"results,":[166],"other":[168],"physical":[169],"findings":[170],"unremarkable.":[172],"accumulation":[174],"averaged":[175],"approximately":[176],"2-fold":[177],"QD":[179],"dosing,":[180],"3-":[182],"4-fold":[184],"BID":[186],"dosing.":[187],"CONCLUSION:":[188],"both":[198],"doses":[199],"well":[201],"tolerated,":[202],"achieved":[203],"measurable":[204],"blood":[205],"levels":[206],"demonstrated":[208],"findings.":[211],"Further":[212],"studies":[213],"will":[214],"be":[215],"needed":[216],"test":[218],"efficacy.":[219]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-05-05T00:00:00"}